Skip to main content
OpenTrials
Completed

NCT Number: NCT02300909

dHACM in Lumbar Decompression and Microdiscectomy Surgery

Prospective evaluation of the safety and efficacy of dHACM on clinical outcomes in lumbar laminectomy and microdiscectomy patients as assessed by Oswestry Disability Index.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital for Special Surgery

New York, 10021, United States

About this study

The objective of this prospective study is to evaluate the safety and efficacy of dHACM on clinical outcomes in lumbar laminectomy and microdiscectomy patients randomized to one of two groups: 1) without dHACM (control) or 2) dHACM.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are 18 (eighteen) years of age or older at the time of surgery.
  • Patients with single- or multi-level spinal stenosis undergoing open lumbar laminectomy, or patients with single-level herniated nucleus pulposus undergoing single-level lumbar microdiscectomy
  • Are willing and able to return for the scheduled follow-up visits, follow post operative instructions and undergo the required radiographic exams for up to 5 time points between 4 weeks and 24 months post-surgery (6 weeks ± 2 weeks, 12 weeks ± 2 weeks, 6 months ±1 month, 1 year±2 months, and 2 years ±2 months post-surgery), including one study MRI-scan at 12 weeks ±2 weeks for the first 20 patients enrolled.
  • Are willing and able to sign study specific informed consent.

Exclusion criteria

  • Non-English speaking patients
  • Non-surgical candidate defined as any patient deemed by the surgeon not to be a surgical candidate cannot participate for the following reasons: that patient does not meet indications for lumbar laminectomy or microdiscectomy surgery, patient has a contraindication to surgery such as medical comorbidities, pregnancy, etc.
  • Allergic to aminoglycoside antibiotics
  • Is a prisoner
  • Is involved in worker's compensation or other litigation relative to the spine injury
  • Has a history of drug or alcohol abuse within the last 12 months
  • Is currently participating in another drug or device clinical trial
  • Previous spinal surgery
  • History of deformity, mechanical instability, or spinal fusion requirement
  • History of hard- or soft-tissue spinal infection
  • Has signs or symptoms of any disease, such as autoimmune disease, which could result in allograft failure, or has experienced allograft failure in the past
  • Patients unable to undergo a MRI

Treatment and study plan

Lumbar Decompression Surgery

Procedure

Lumbar Decompression Surgery

Microdiscectomy Surgery

Procedure

Microdiscectomy Surgery

Dehydrated Human Amnion/Chorion Membrane (dHACM)

Other

Application of Dehydrated Human Amnion/Chorion Membrane (dHACM)

Primary outcomes

  1. Oswestry Disability Index

    Time frame: 2 years

    Patient Functional Outcomes Questionnaire

Secondary outcomes

  1. Re-operation (Number of patients having re-operation during study)

    Time frame: 2 years

    Number of patients having re-operation during study

  2. Scar formation in revision cases

    Time frame: 2 years

    Dissection of scar formation required at re-operation

  3. Quality of Life (VAS Pain)

    Time frame: 2 years

    VAS Pain

  4. Quality of Life (SF-36)

    Time frame: 2 years

    SF-36

  5. Quality of Life

    Time frame: 2 years

    HSS Lumbar Expectations Survey

Other outcomes

  1. MRI findings in first 20 patients

    Time frame: 3 months post-op

Sponsors and collaborators

Lead sponsor

MiMedx Group, Inc.

Industry

Collaborators

  • Hospital for Special Surgery, New York

Registry information

Official study title

A Randomized, Single Blind, Controlled Trial of Clinical Outcomes of Dehydrated Human Amnion/Chorion Membrane (dHACM) in Lumbar Decompression and Microdiscectomy Surgery

Important dates

Study start
2014
Primary completion
2018
Study completion
2018
First posted
Nov 25, 2014
Registry last updated
Aug 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.